chapter 97 Factory Director Zhou Shiwen

In the end, the two parties finalized it, with Tymon Well providing the prescription, and Zhou Huaiyu responsible for applying for approval, production, operation, and sales promotion. The medicinal materials belong to the future medicinal materials base, and the pharmaceutical factory pays the base based on the price. After deducting all expenses from the sales, Tymon Well will be divided into 80% and Zhou Huaiyu at 20%. If they expand to a larger pharmaceutical factory in the future,...